Related Experiment Video
Updated: Feb 8, 2026
06:51
A Preclinical Murine Model of Hepatic Metastases
Published on: September 27, 2014
30.4K
Peritoneal Metastases, a Frontier for Progress.
1Program in Peritoneal Surface Oncology, Center for Gastrointestinal Malignancies, MedStar Washington Hospital Center, 106 Irving Street, Northwest, Suite 3900, Washington, DC 20010, USA.
Surgical Oncology Clinics of North America
|June 25, 2018
Summary
Standardized treatments for peritoneal metastases combine surgery and chemotherapy. Hyperthermia enhances chemotherapy
Area of Science:
- Oncology
- Surgical Oncology
- Medical Oncology
Background:
- Peritoneal metastases treatment has evolved significantly over 30 years.
- Current clinical trials aim to standardize treatment regimens.
- Multinational efforts involve global centers of excellence.
Purpose of the Study:
- To optimize standardized treatment regimens for peritoneal metastases.
- To evaluate the essential components of a successful management plan.
- To highlight the role of cytoreductive surgery and chemotherapy.
Main Methods:
- Cytoreductive surgery.
- Intraperitoneal chemotherapy administration.
- Moderate hyperthermia to enhance cytotoxicity.
- Careful patient selection using prognostic indicators.
Main Results:
- A successful management plan integrates cytoreductive surgery and intraperitoneal chemotherapy.
- Moderate hyperthermia significantly increases chemotherapy's effectiveness.
- Well-defined prognostic indicators are crucial for patient selection.
Conclusions:
- Standardized treatment regimens for peritoneal metastases are being optimized.
- The combination of cytoreductive surgery, hyperthermia, and intraperitoneal chemotherapy is essential.
- Multinational collaboration is key to advancing treatment strategies.
Keywords:
Appendiceal mucinous neoplasmsColorectal cancerHIPECHyperthermiaIntraperitoneal chemotherapyPseudomyxoma peritoneiMore Related Videos
Related Concept Videos
01:25Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
848
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
848
02:07Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
01:30Peritoneal Dialysis I: Introduction and Procedure
3.3K
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
3.3K
03:03mTOR Signaling and Cancer Progression
4.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.8K
01:25Peritoneal Dialysis III: Nursing Management
871
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
871
01:30Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
534
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
534